Chatham Capital Group’s United Therapeutics UTHR Stock Holding History

Chatham Capital Group’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,994	Closed	-$2.16M	–	193
2021 Q4	$2.16M	Buy	9,994 +15	+0.2%	+$3.24K	0.39%	69
2021 Q3	$1.85M	Sell	9,979 -198	-2%	-$36.6K	0.36%	74
2021 Q2	$1.83M	Buy	10,177 +1	+0%	+$179	0.35%	76
2021 Q1	$1.7M	Buy	10,176 +185	+2%	+$30.9K	0.36%	80
2020 Q4	$1.52M	Sell	9,991 -60	-0.6%	-$9.11K	0.34%	79
2020 Q3	$1.02M	Sell	10,051 -40	-0.4%	-$4.04K	0.25%	88
2020 Q2	$1.22M	Buy	10,091 +46	+0.5%	+$5.57K	0.32%	80
2020 Q1	$953K	Sell	10,045 -35	-0.3%	-$3.32K	0.28%	83
2019 Q4	$888K	Sell	10,080 -85	-0.8%	-$7.49K	0.22%	100
2019 Q3	$811K	Sell	10,165 -170	-2%	-$13.6K	0.21%	104
2019 Q2	$807K	Buy	10,335 +71	+0.7%	+$5.54K	0.2%	100
2019 Q1	$1.21M	Buy	10,264 +74	+0.7%	+$8.69K	0.31%	85
2018 Q4	$1.11M	Buy	10,190 +900	+10%	+$98K	0.31%	81
2018 Q3	$1.19M	Hold	9,290	–	–	0.3%	79
2018 Q2	$1.05M	Buy	9,290 +200	+2%	+$22.6K	0.28%	80
2018 Q1	$1.02M	Sell	9,090 -600	-6%	-$67.4K	0.27%	78
2017 Q4	$1.43M	Buy	9,690 +80	+0.8%	+$11.8K	0.39%	57
2017 Q3	$1.13M	Hold	9,610	–	–	0.32%	70
2017 Q2	$1.25M	Buy	9,610 +618	+7%	+$80.2K	0.35%	60
2017 Q1	$1.22M	Sell	8,992 -1,018	-10%	-$138K	0.34%	63
2016 Q4	$1.44M	Buy	10,010 +1,800	+22%	+$258K	0.42%	57
2016 Q3	$969K	Sell	8,210 -400	-5%	-$47.2K	0.31%	68
2016 Q2	$912K	Buy	8,610 +100	+1%	+$10.6K	0.28%	70
2016 Q1	$948K	Buy	8,510 +200	+2%	+$22.3K	0.3%	69
2015 Q4	$1.3M	Hold	8,310	–	–	0.42%	51
2015 Q3	$1.09M	Sell	8,310 -400	-5%	-$52.5K	0.37%	52
2015 Q2	$1.52M	Hold	8,710	–	–	0.43%	52
2015 Q1	$1.5M	Buy	8,710 +150	+2%	+$25.9K	0.44%	48
2014 Q4	$1.11M	Hold	8,560	–	–	0.33%	62
2014 Q3	$1.1M	Buy	8,560 +100	+1%	+$12.9K	0.34%	57
2014 Q2	$749K	Hold	8,460	–	–	0.29%	72
2014 Q1	$795K	Hold	8,460	–	–	0.33%	68
2013 Q4	$957K	Sell	8,460 -150	-2%	-$17K	0.4%	53
2013 Q3	$679K	Hold	8,610	–	–	0.31%	72
2013 Q2	$567K	Buy	+8,610	New	+$567K	0.28%	77